TACKE, MD, PHD, U.; UOSUKAINEN, MSCI (PHARM), H.; KANANEN, BSCI (PHARM), M.; KONTRA, PHARM LIC, K.; PENTIKÄINEN, MD, H. A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine—naloxone combination. Journal of Opioid Management, [S. l.], v. 5, n. 6, p. 321–329, 2018. DOI: 10.5055/jom.2009.0032. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/950. Acesso em: 25 apr. 2024.